# EDGAR Filing Document

**Accession Number:** 0001454789
**File Stem:** 0001104659-23-021436
**Filing Date:** 2023-2
**Character Count:** 18364
**Document Hash:** 5d8a39784dc3f824ffc9f84058e36177
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-23-021436.hdr.sgml**: 20230214

**ACCESSION NUMBER**: 0001104659-23-021436

**CONFORMED SUBMISSION TYPE**: SC 13G/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230214

**DATE AS OF CHANGE**: 20230214

**GROUP MEMBERS**: FAIRMOUNT HEALTHCARE FUND GP LLC

**GROUP MEMBERS**: FAIRMOUNT HEALTHCARE FUND II GP LLC

**GROUP MEMBERS**: FAIRMOUNT SPV I, LLC

**GROUP MEMBERS**: FAIRMOUNT SPV II, LLC

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Astria Therapeutics, Inc.
- **CENTRAL INDEX KEY:** 0001454789
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 13G/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-88910
- **FILM NUMBER:** 23628181

**BUSINESS ADDRESS:**
- **STREET 1:** 75 STATE STREET
- **STREET 2:** SUITE 1400
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02109
- **BUSINESS PHONE:** 617-349-1971

**MAIL ADDRESS:**
- **STREET 1:** 75 STATE STREET
- **STREET 2:** SUITE 1400
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02109

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CATABASIS PHARMACEUTICALS INC
- **DATE OF NAME CHANGE:** 20090127
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Fairmount Funds Management LLC
- **CENTRAL INDEX KEY:** 0001802528
- **IRS NUMBER:** 364841215
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 13G/A

**BUSINESS ADDRESS:**
- **STREET 1:** 200 BARR HARBOR DRIVE
- **STREET 2:** SUITE 400
- **CITY:** WEST CONSHOHOCKEN
- **STATE:** PA
- **ZIP:** 19428
- **BUSINESS PHONE:** 267-262-5300

**MAIL ADDRESS:**
- **STREET 1:** 200 BARR HARBOR DRIVE
- **STREET 2:** SUITE 400
- **CITY:** WEST CONSHOHOCKEN
- **STATE:** PA
- **ZIP:** 19428

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**SCHEDULE 13G**

**Under the Securities Exchange Act of 1934**

**(Amendment No.3)\***

**Astria Therapeutics, Inc.**

**(Name of Issuer)**

**Common Stock, Par Value $0.001**

**(Title of Class of Securities)**

**04635X102**

**(CUSIP Number)**

**December 31, 2022**

**(Date of Event Which Requires Filing of This Statement)**

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

◻ Rule 13d-1(b)

⌧ Rule 13d-1(c)

◻ Rule 13d-1(d)

\* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 04635X102

1. Names of Reporting Persons I.R.S. Identification No. of Above Persons (Entities Only) Fairmount Funds Management LLC

2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) ◻ (b) ◻

3. SEC Use Only

4. Citizenship or Place of Organization Delaware

---

| | | |
|:---|:---|:---|
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person<br> With | 5. | Sole Voting Power<br>0 |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person<br> With | 6. | Shared Voting Power<br>1,901,397  |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person<br> With | 7. | Sole Dispositive Power<br>0  |
| Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person<br> With | 8. | Shared Dispositive Power<br>1,901,397 |

---

9. Aggregate Amount Beneficially Owned by Each Reporting Person 1,901,397

10. Check if the
 Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ◻

11. Percent of Class Represented by Amount in Row (9) 6.9%<sup>(1)</sup>

12. Type of Reporting Person (See Instructions) IA

(1) Calculated based on 27,501,340 shares of the Issuer's Common Stock outstanding as of December 30, 2022, as disclosed on Form 8-K filed by the Issuer with the Securities and Exchange Commission on January 5, 2023.

CUSIP No. 04635X102

1. Names of Reporting Persons I.R.S. Identification No. of Above Persons (Entities Only) Fairmount SPV I, LLC

2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) ◻ (b) ◻

3. SEC Use Only

4. Citizenship or Place of Organization Delaware

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person<br> With | 5. | Sole Voting Power<br>0 |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person<br> With | 6. | Shared Voting Power<br>0 |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person<br> With | 7. | Sole Dispositive Power<br>0  |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person<br> With | 8. | Shared Dispositive Power<br>0 |

---

9. Aggregate Amount Beneficially Owned by Each Reporting Person 0

10. Check if the
 Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ◻

11. Percent of Class Represented by Amount in Row (9) 0.0%

12. Type of Reporting Person (See Instructions) OO

CUSIP No. 04635X102

1. Names of Reporting Persons I.R.S. Identification No. of Above Persons (Entities Only) Fairmount SPV II, LLC

2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) ◻ (b) ◻

3. SEC Use Only

4. Citizenship or Place of Organization Delaware

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person<br> With | 5. | Sole Voting Power<br>0 |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person<br> With | 6. | Shared Voting Power<br>0 |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person<br> With | 7. | Sole Dispositive Power<br>0  |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person<br> With | 8. | Shared Dispositive Power<br>0 |

---

9. Aggregate Amount Beneficially Owned by Each Reporting Person 0

10. Check if the
 Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ◻

11. Percent of Class Represented by Amount in Row (9) 0.0%

12. Type of Reporting Person (See Instructions) OO

CUSIP No. 04635X102

1. Names of Reporting Persons I.R.S. Identification No. of Above Persons (Entities Only) Fairmount Healthcare Fund GP LLC

2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) ◻ (b) ◻

3. SEC Use Only

4. Citizenship or Place of Organization Delaware

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person<br> With | 5. | Sole Voting Power<br>0 |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person<br> With | 6. | Shared Voting Power<br>59,953 |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person<br> With | 7. | Sole Dispositive Power<br>0  |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person<br> With | 8. | Shared Dispositive Power<br>59,953 |

---

9. Aggregate Amount Beneficially Owned by Each Reporting Person 59,953

10. Check if the
 Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ◻

11. Percent of Class Represented by Amount in Row (9) 0.2%<sup>(1)</sup>

12. Type of Reporting Person (See Instructions) OO

(1) Calculated based on 27,501,340 shares of the Issuer's Common Stock outstanding as of December 30, 2022, as disclosed on Form 8-K filed by the Issuer with the Securities and Exchange Commission on January 5, 2023.

CUSIP No. 04635X102

1. Names of Reporting Persons I.R.S. Identification No. of Above Persons (Entities Only) Fairmount Healthcare Fund II GP LLC

2. Check the Appropriate Box if a Member of a Group (See Instructions) (a) ◻ (b) ◻

3. SEC Use Only

4. Citizenship or Place of Organization Delaware

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person<br> With | 5. | Sole Voting Power<br>0 |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person<br> With | 6. | Shared Voting Power<br>1,841,444 |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person<br> With | 7. | Sole Dispositive Power<br>0  |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially<br> Owned by<br> Each<br> Reporting<br> Person<br> With | 8. | Shared Dispositive Power<br>1,841,444 |

---

9. Aggregate Amount Beneficially Owned by Each Reporting Person 1,841,444

10. Check if the
 Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) ◻

11. Percent of Class Represented by Amount in Row (9) 6.7%<sup>(1)</sup>

12. Type of Reporting Person (See Instructions) OO

(1) Calculated based on 27,501,340 shares of the Issuer's Common Stock outstanding as of December 30, 2022, as disclosed on Form 8-K filed by the Issuer with the Securities and Exchange Commission on January 5, 2023.

**Item 1.**

(a) Name of Issuer

Astria Therapeutics, Inc.

(b) Address of Issuer's Principal Executive Offices

75 State Street, Suite 1400, Boston, MA 02109

**Item 2.**

This Amendment No. 3 to Schedule 13G amends and restates the statements on Schedule 13G originally filed on December 31, 2021, Amendment No. 1 thereto filed on September 22, 2021, and Amendment No. 2 thereto filed on June 17, 2021.

(a) Name of Person(s) Filing:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A) Fairmount Funds Management LLC

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B) Fairmount SPV I, LLC

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(C) Fairmount SPV II, LLC

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(D) Fairmount Healthcare Fund GP LLC

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(E) Fairmount Healthcare Fund II GP LLC

(b) Address of Principal Business Office or, if none, Residence:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A) 200 Barr Harbor Drive, Suite 400, West Conshohocken, PA 19428

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B) 200 Barr Harbor Drive, Suite 400, West Conshohocken, PA 19428

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(C) 200 Barr Harbor Drive, Suite 400, West Conshohocken, PA 19428

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(D) 200 Barr Harbor Drive, Suite 400, West Conshohocken, PA 19428

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(E) 200 Barr Harbor Drive, Suite 400, West Conshohocken, PA 19428

(c) Citizenship:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A) Delaware

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B) Delaware

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(C) Delaware

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(D) Delaware

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(E) Delaware

(d) Title of Class of Securities:

Common Stock, Par Value $0.001

(e) CUSIP Number:

04635X102

**Item 3.** **If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:**

Not applicable.

(a) Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);

(b) Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);

(c) Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);

(d) Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);

(e) An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

(f) An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);

(g) A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);

(h) A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i) A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j) A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);

(k) Group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution: _______________.

**Item 4.** **Ownership**

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

(a), (b), and (c)

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Reporting Persons\*** | **Number of<br> Shares<br> With Sole<br> Voting<br> and<br> Dispositive<br> Power** | **Number of<br> Shares<br> With Shared<br> Voting<br> and<br> Dispositive<br> Power** | **Aggregate<br> Number of<br> Shares<br> Beneficially<br> Owned** | **Percentage<br> of Class<br> Beneficially<br> Owned\*\*** |
| Fairmount Funds Management LLC | 0 | 1901397 | 1901397 | 6.9% |
| Fairmount SPV I, LLC | 0 | 0 | 0 | 0.0% |
| Fairmount SPV II, LLC | 0 | 0 | 0 | 0.0% |
| Fairmount Healthcare Fund GP LLC | 0 | 59953 | 59953 | 0.2% |
| Fairmount Healthcare Fund II GP LLC | 0 | 1841444 | 1841444 | 6.7% |

---

\* The above figures reflect the beneficial ownership for the Reporting Persons above as of December 31, 2022.

\*\* The percentages reported above are calculated based on 27,501,340 shares of the Issuer's Common Stock outstanding as of December 30, 2022. Percentages shown above subject to rounding adjustments.

**Item 5.** **Ownership of Five Percent or Less of a Class**

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ◻.

**Item 6.** **Ownership of More than Five Percent on Behalf of Another Person**

Not applicable.

**Item 7.** **Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person**

Not applicable.

**Item 8.** **Identification and Classification of Members of the Group**

Not applicable.

**Item 9.** **Notice of Dissolution of Group**

Not applicable.

**Item 10.** **Certification**

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

**Signature**

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 14, 2023

---

| | | |
|:---|:---|:---|
| **FAIRMOUNT FUNDS MANAGEMENT LLC** | **FAIRMOUNT FUNDS MANAGEMENT LLC** | **FAIRMOUNT FUNDS MANAGEMENT LLC** |
| By: | /s/ Peter Harwin | /s/Tomas Kiselak  |
| Name: | Peter Harwin | Tomas Kiselak |
| Title: | Managing Member | Managing Member |

---

---

| | | |
|:---|:---|:---|
| **FAIRMOUNT SPV I, LLC** | **FAIRMOUNT SPV I, LLC** | **FAIRMOUNT SPV I, LLC** |
| By: | /s/ Peter Harwin | /s/Tomas Kiselak  |
| Name: | Peter Harwin | Tomas Kiselak |
| Title: | Managing Member | Managing Member |

---

---

| | | |
|:---|:---|:---|
| **FAIRMOUNT SPV II, LLC** | **FAIRMOUNT SPV II, LLC** | **FAIRMOUNT SPV II, LLC** |
| By: | /s/ Peter Harwin | /s/Tomas Kiselak  |
| Name: | Peter Harwin | Tomas Kiselak |
| Title: | Managing Member | Managing Member |

---

---

| | | |
|:---|:---|:---|
| **FAIRMOUNT HEALTHCARE FUND GP LLC** | **FAIRMOUNT HEALTHCARE FUND GP LLC** | **FAIRMOUNT HEALTHCARE FUND GP LLC** |
| By: | /s/ Peter Harwin | /s/Tomas Kiselak  |
| Name: | Peter Harwin | Tomas Kiselak |
| Title: | Managing Member | Managing Member |

---

---

| | | |
|:---|:---|:---|
| **FAIRMOUNT HEALTHCARE FUND II GP LLC** | **FAIRMOUNT HEALTHCARE FUND II GP LLC** | **FAIRMOUNT HEALTHCARE FUND II GP LLC** |
| By: | /s/ Peter Harwin | /s/Tomas Kiselak  |
| Name: | Peter Harwin | Tomas Kiselak |
| Title: | Managing Member | Managing Member |

---